I recommend waiting for a better discount before investing in Abeona Therapeutics Inc. (ABEO).

After finishing at $4.11 in the prior trading day, Abeona Therapeutics Inc. (NASDAQ: ABEO) closed at $3.94, down -4.14%. In other words, the price has decreased by -$0.1700 from its previous closing price. On the day, 195905 shares were traded. ABEO stock price reached its highest trading level at $4.1800 during the session, while it also had its lowest trading level at $3.8800.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Ratios:

Our goal is to gain a better understanding of ABEO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.00 and its Current Ratio is at 2.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

On September 18, 2020, B. Riley FBR started tracking the stock assigning a Buy rating and target price of $5.

On February 10, 2020, SVB Leerink started tracking the stock assigning a Outperform rating and target price of $6.SVB Leerink initiated its Outperform rating on February 10, 2020, with a $6 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 when O’Malley Brendan M. bought 7,500 shares for $3.99 per share. The transaction valued at 29,925 led to the insider holds 87,961 shares of the business.

Vazzano Joseph Walter bought 2,500 shares of ABEO for $10,000 on Nov 18. The Chief Financial Officer now owns 95,250 shares after completing the transaction at $4.00 per share. On Jun 15, another insider, Alvino Mark, who serves as the Director of the company, sold 20,000 shares for $0.15 each. As a result, the insider received 3,098 and left with 27,181 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 15.47 while its Price-to-Book (P/B) ratio in mrq is 1.64.

Stock Price History:

Over the past 52 weeks, ABEO has reached a high of $20.74, while it has fallen to a 52-week low of $2.70. The 50-Day Moving Average of the stock is 3.9560, while the 200-Day Moving Average is calculated to be 4.9243.

Shares Statistics:

The stock has traded on average 470.66K shares per day over the past 3-months and 371.87k shares per day over the last 10 days, according to various share statistics. A total of 17.18M shares are outstanding, with a floating share count of 15.36M. Insiders hold about 3.20% of the company’s shares, while institutions hold 7.20% stake in the company. Shares short for ABEO as of Oct 13, 2022 were 607.25k with a Short Ratio of 0.72M, compared to 177.51k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 10.21% and a Short% of Float of 10.33%.

Earnings Estimates

Its stock is currently analyzed by 3 different market analysts. On average, analysts expect EPS of -$1.47 for the current quarter, with a high estimate of -$0.95 and a low estimate of -$1.76, while EPS last year was -$1.75. The consensus estimate for the next quarter is -$1.19, with high estimates of -$0.77 and low estimates of -$1.66.

Analysts are recommending an EPS of between -$1.33 and -$8.98 for the fiscal current year, implying an average EPS of -$5.33. EPS for the following year is -$1.65, with 2 analysts recommending between -$1.3 and -$2.01.